Primitive macrophages induce sarcomeric maturation and functional enhancement of developing human cardiac microtissues via efferocytic pathways
Homaira Hamidzada,Simon Pascual-Gil,Qinghua Wu,Gregory M Kent,Stéphane Massé,Crystal Kantores,Uros Kuzmanov,M Juliana Gomez-Garcia,Naimeh Rafatian,Renée A Gorman,Marianne Wauchop,Wenliang Chen,Shira Landau,Tasnia Subha,Michael H Atkins,Yimu Zhao,Erika Beroncal,Ian Fernandes,Jared Nanthakumar,Shabana Vohra,Erika Y Wang,Tamilla Valdman Sadikov,Babak Razani,Tracy L McGaha,Ana C Andreazza,Anthony Gramolini,Peter H Backx,Kumaraswamy Nanthakumar,Michael A Laflamme,Gordon Keller,Milica Radisic,Slava Epelman
DOI: https://doi.org/10.1038/s44161-024-00471-7
Abstract:Yolk sac macrophages are the first to seed the developing heart, however we have no understanding of their roles in human heart development and function due to a lack of accessible tissue. Here, we bridge this gap by differentiating human embryonic stem cells (hESCs) into primitive LYVE1+ macrophages (hESC-macrophages) that stably engraft within contractile cardiac microtissues composed of hESC-cardiomyocytes and fibroblasts. Engraftment induces a human fetal cardiac macrophage gene program enriched in efferocytic pathways. Functionally, hESC-macrophages trigger cardiomyocyte sarcomeric protein maturation, enhance contractile force and improve relaxation kinetics. Mechanistically, hESC-macrophages engage in phosphatidylserine dependent ingestion of apoptotic cardiomyocyte cargo, which reduces microtissue stress, leading hESC-cardiomyocytes to more closely resemble early human fetal ventricular cardiomyocytes, both transcriptionally and metabolically. Inhibiting hESC-macrophage efferocytosis impairs sarcomeric protein maturation and reduces cardiac microtissue function. Taken together, macrophage-engineered human cardiac microtissues represent a considerably improved model for human heart development, and reveal a major beneficial role for human primitive macrophages in enhancing early cardiac tissue function.